[1PW20-1] Chemoprevention of hepatocellular carcinoma by acyclic retinoid

〇Masahito Shimizu¹ (1.Dept. of Gastroenterol., Gifu Univ., Grad. Sch. of Med.)

ConBio2017 |Wed. Dec 6, 2017 4:00 PM - 4:25 PM

[1PW20-2] Retinoid nuclear receptors independent inhibition of hepatocarcinogenesis by acyclic retinoid peretinoin

〇Masao Honda^1,2, Taro Yamashita¹, Hikari Okada¹, Shuichi Kaneko¹ (1.Dept. of Gastroenterol. Kanazawa Univ., 2.Dept. of Labo. Med. Kanazawa Univ.)

ConBio2017 |Wed. Dec 6, 2017 4:25 PM - 4:50 PM

[1PW20-3] Significance of retinoids in the process of liver carcinogenesis

〇Goshi Shiota¹ (1.Division of Molecular and Genetic Medicine, Tottori University)

ConBio2017 |Wed. Dec 6, 2017 4:50 PM - 5:15 PM

[1PW20-4] Biology of Geranylgeranoic Acid

〇Yoshihiro Shidoji¹ (1.Mol. & Cellular Biol., Grad. Sch. of Human Health Sci., Univ. of Nagasaki)

ConBio2017 |Wed. Dec 6, 2017 5:15 PM - 5:40 PM

[1PW20-5] Precancerous subpopulation of oval cells is a therapeutic target for HCC

〇Yun-Wen Zheng^1,2, Tomonori Tsuchida², Naoto Ishibashi³, Hideki Taniguchi² (1.Univ. of Tsukuba Faculty of Med., 2.Yokohama City Univ. Sch. of Med., 3.Kowa Ltd. Tokyo New Drug Res Lab　)

ConBio2017 |Wed. Dec 6, 2017 5:40 PM - 6:05 PM

[1PW20-6] Molecular mechanisms by which acyclic retinoid induces apoptosis in MYCN (+) liver cancer stem cells

〇Soichi Kojima¹ (1.RIKEN CLST)

ConBio2017 |Wed. Dec 6, 2017 6:05 PM - 6:30 PM

[1PW21-Introduction] Introduction

〇Masafumi Ihara¹ (1.National Cerebral and Cardiovascular Center)

ConBio2017 |Wed. Dec 6, 2017 4:00 PM - 4:02 PM

[1PW21-1] Intramural Periarterial Drainage and the pathology of Alzheimer's disease

〇Roxana Carare¹ (1.University of Southampton)

ConBio2017 |Wed. Dec 6, 2017 4:02 PM - 4:32 PM

[1PW21-2] The roles of pericyte and oligodendrocyte precursor cell in vascular dementia

〇Takakuni Maki¹ (1.Dept. of Neurol., Grad. Sch. of Med., Univ. of Kyoto)

ConBio2017 |Wed. Dec 6, 2017 4:32 PM - 4:55 PM

[1PW21-3] In vitro model of CADASIL: iPS cell-derived mural cells for unraveling the pathogenesis of a hereditary small vessel disease

〇Yumi Yamamoto¹, Katsutoshi Kojima², Daisuke Taura², Masakatsu Sone², Kazuo Washida³, Naohiro Egawa⁴, Takayuki Kondo⁴, Eiko Minagawa⁵, Kayoko Tsukita⁴, Takako Eanmi⁴, Hidekazu Tomimoto⁶, Toshiki Mizuno⁷, Ryosuke Takahashi⁸, Masafumi Ihara⁹, Haruhisa Inoue⁴ (1.Dept. of Regen. Med. Tissue Eng., Nat. Cereb. Cardiovasc. Center Res. Institute, 2.Dept. of Diabetes, Endocrin. Nutr., Grad. Sch. of Med., Kyoto Univ., 3.Div. of Neurol., Grad. Sch. of Kobe Univ., 4.CiRA, Kyoto Univ., 5.Dept. of Degen. Neurol. Dis., National Institute of Neuroscience, Nat. Center of Neurol. and Psychiatr., 6.Dept. of Dementia Prevention and Therapeutics, Grad. Sch. of Med., Mie Univ., 7.Dept. of Neurol., Kyoto Prefectural Univ. of Med., 8.Dept. of Neurol., Kyoto Univ. Grad. Sch. of Med., 9.Dept. of Stroke and Cerebrovasc. Dis., Nat. Cereb. Cardiovasc. Center Res. Institute)

ConBio2017 |Wed. Dec 6, 2017 4:55 PM - 5:18 PM